project: cardiodx

CardioDX logo

Connect with a Sales Specialist

x

Corus CAD

Corus CAD is the only blood test that, along with a clinical assessment, can quickly, accurately, and safely help clinicians rule out obstructive coronary artery disease (CAD) in symptomatic patients.

For Clinicians For Patients

Women and Heart Disease

CAD, one of the most common types of heart disease, can be difficult to diagnose in women. The Corus CAD blood test can help clinicians assess the likelihood that obstructive CAD is the cause of chest discomfort or other symptoms in stable, female patients.

Read more

What's New?

MD+DI
April 04, 2016

The Corus CAD blood test from CardioDx has new data to back its predictive powers. In a new substudy, Corus CAD, which is used to test patients for the likelihood of...

Read more

Fox News
March 02, 2016

For those experiencing non-urgent symptoms, there is a simple sex-specific blood test called Corus CAD -- which is especially beneficial for women – in helping docto...

Read more

The Washington Post
February 22, 2016

Where men and women differ is how they respond to heart disease and how they manifest symptoms. Roughly two-thirds of women who suddenly die of coronary heart diseas...

Read more

Rush University Medical Center
February 15, 2016

Annabelle S. Volgman, MD, one of the committee members behind the report, urges women and their loved ones to start taking a three-pronged approach regarding their h...

Read more

WTOP, Washington’s Top News
September 21, 2015

About a year ago, Ghosh started using a diagnostic tool to help her better identify the patients who really need to see a cardiologist for further CAD testing and tr...

Read more

Press Releases

April 04, 2016
PROMISE Trial Substudy Demonstrates That The Corus CAD Blood Test Is Associated With Clinical Events Among Patients Being Evaluated for Suspected Obstructive Coronary Artery Disease

Read more

March 02, 2016
Commentary in The American Journal of Medicine Reinforces the Value of the Corus CAD Test in Evaluating Symptomatic Patients With Suspected Obstructive Coronary Artery Disease

Read more

December 14, 2015
Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer

Read more

November 10, 2015
Multi-Center, Community-Based Patient Registry Interim Results Presented at the AHA Scientific Sessions Support the Clinical Utility of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease

Read more

September 30, 2015
CardioDx Announces Positive Data from a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women

Read more